LV11940A - The use of melatonin for the treatment of people who are dependent on grass - Google Patents

The use of melatonin for the treatment of people who are dependent on grass

Info

Publication number
LV11940A
LV11940A LV970144A LV970144A LV11940A LV 11940 A LV11940 A LV 11940A LV 970144 A LV970144 A LV 970144A LV 970144 A LV970144 A LV 970144A LV 11940 A LV11940 A LV 11940A
Authority
LV
Latvia
Prior art keywords
melatonin
grass
dependent
people
treatment
Prior art date
Application number
LV970144A
Other languages
Latvian (lv)
Other versions
LV11940B (en
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of LV11940A publication Critical patent/LV11940A/en
Publication of LV11940B publication Critical patent/LV11940B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LVP-97-144A 1995-02-01 1997-07-24 APPLICATION OF MELATONINE TO TREATMENT OF PERSONS RESPONSIBLE FOR MEDICINAL PRODUCTS \ t LV11940B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
LV11940A true LV11940A (en) 1998-01-20
LV11940B LV11940B (en) 1998-05-20

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-144A LV11940B (en) 1995-02-01 1997-07-24 APPLICATION OF MELATONINE TO TREATMENT OF PERSONS RESPONSIBLE FOR MEDICINAL PRODUCTS \ t

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016918A (en) 2000-01-05 2004-03-23 Neurim Pharma 1991 Process and formulation for treating antihypertensive resistance and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
CA2861111C (en) 2012-01-26 2021-11-23 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2805376T3 (en) 2012-12-18 2021-02-11 Vanda Pharmaceuticals Inc Tasimelteon for treating circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3777842A1 (en) * 2016-10-31 2021-02-17 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229490T2 (en) * 1991-05-09 2000-02-17 Neurim Pharma 1991 Medicines containing melatonin
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
PL183148B1 (en) 2002-05-31
MD970254A (en) 1999-05-31
DK176081B1 (en) 2006-04-18
NZ298878A (en) 1999-05-28
SK284521B6 (en) 2005-05-05
BG62876B1 (en) 2000-10-31
SK103097A3 (en) 1998-01-14
AU4457496A (en) 1996-08-21
CZ240597A3 (en) 1998-01-14
LV11940B (en) 1998-05-20
AU695366B2 (en) 1998-08-13
SI9620022A (en) 1998-10-31
LU90118B1 (en) 1997-11-13
IS1980B (en) 2005-01-14
ATA901396A (en) 2001-02-15
CZ291349B6 (en) 2003-02-12
TR199700723T1 (en) 1998-02-21
CN1172431A (en) 1998-02-04
CN1083263C (en) 2002-04-24
IS4532A (en) 1997-07-25
FI119586B (en) 2009-01-15
MD1716B2 (en) 2001-08-31
JP4516159B2 (en) 2010-08-04
NO312814B1 (en) 2002-07-08
FI973185A (en) 1997-09-30
PL321630A1 (en) 1997-12-08
NO973531D0 (en) 1997-07-31
TW483757B (en) 2002-04-21
BG101803A (en) 1998-04-30
EE03384B1 (en) 2001-04-16
AT408188B (en) 2001-09-25
NO973531L (en) 1997-09-30
EE9700166A (en) 1998-02-16
WO1996023496A1 (en) 1996-08-08
DK89697A (en) 1997-07-30
BR9607169A (en) 1997-11-11
FI973185A0 (en) 1997-07-31
MD1716C2 (en) 2002-02-28
JPH10513177A (en) 1998-12-15
MX9705856A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
NO991381D0 (en) Combination therapy for the treatment of psychoses
FI952926A0 (en) Procedures for the treatment and prevention of all Procedures for the treatment and prevention of allergies ergies
NO982172D0 (en) Use of epinastine for the treatment of pain
DE69600307D1 (en) Respirator for the treatment of respiratory insufficiency
FI971568A (en) Procedure for the treatment of resistant tumors
DE69626539D1 (en) topical use of vitamin D for the treatment of eye diseases
DK19893A (en) NASAL TREATMENT PREPARATION
DE69620691T2 (en) Therapeutic agent for the treatment of hypercholesterolemia
NO991459L (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
LV11940A (en) The use of melatonin for the treatment of people who are dependent on grass
NO983512D0 (en) Means for the treatment and prevention of AIDS
ATE347372T1 (en) VACCINES FOR THE TREATMENT OF MYCOSIS
NO995231D0 (en) Therapeutic treatment of skin disorders
DE69604071D1 (en) OXAZOLIDINONE DERIVATIVES, THEIR PRODUCTION AND THEIR THERAPEUTIC USE
DE69735417D1 (en) 2,5-DIHYDROXYBENZYLSULFON DERIVATIVES FOR THE TREATMENT OF SEXUAL DISORDERS
NO994258L (en) Use of levobupivacaine for the treatment of facial migraines
NO984432L (en) Procedure for the treatment of migraine pain
NO913117D0 (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
EE9700235A (en) Benzenamides for the treatment of neurodegenerative diseases
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
NO942756D0 (en) Treatment of glaucoma
NO984189D0 (en) Procedure for the treatment of bipolar disorder
NO982562D0 (en) Composition for the treatment of pain
DE69739190D1 (en) MEDICAMENT FOR THE TREATMENT OF OCULAR CRUSH DISEASES
NO20002481D0 (en) Combination therapy for the treatment of AIDS